无容量
医学
围手术期
新辅助治疗
肺癌
佐剂
化疗
肿瘤科
内科学
外科
癌症
免疫疗法
乳腺癌
作者
Tina Cascone,Mark M. Awad,Jonathan Spicer,Jie He,Shun Lü,Boris Sepesi,Fumihiro Tanaka,Janis M. Taube,Robin Cornelissen,Libor Havel,Nina Karaseva,Jarosław Kużdżał,Luboš Petruželka,Lin Wu,Jean-Louis Pujol,Hiroyuki Ito,Tudor–Eliade Ciuleanu,Ludmila de Oliveira Muniz Koch,Annelies Janssens,Aurelia Alexandru
标识
DOI：10.1056/nejmoa2311926
摘要
Perioperative treatment with nivolumab resulted in significantly longer event-free survival than chemotherapy in patients with resectable NSCLC. No new safety signals were observed. (Funded by Bristol Myers Squibb; CheckMate 77T ClinicalTrials.gov number, NCT04025879.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
OsamaKareem
Twonej
科研狗
风声3492881045
sinmon
张欢馨
殷勤的紫槐
Nexus
干净的琦
GingerF
贪玩的秋柔
蓝天
畔畔
AllRightReserved
小安
Mic
风清扬
大力的灵雁
乐空思
皖公网安备34019202002308
